BZLF2 (AA 34-223) Antikörper (HRP)
Kurzübersicht für BZLF2 (AA 34-223) Antikörper (HRP) (ABIN7141315)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 34-223
-
Kreuzreaktivität
- Epstein-Barr Virus (EBV)
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Epstein-Barr virus Glycoprotein 42 protein (34-223AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- BZLF2
-
Hintergrund
-
Background: Plays a role in virion attachment to host B-lymphocytes, through binding to leukocyte antigen (HLA) class II and subsequently participates in fusion of the virion with host membranes. May act as a tropism switch that directs fusion with B-lymphocytes and inhibits fusion with epithelial cells. Additionally, hampers T-cell recognition via HLA class II molecules through steric hindrance of T-cell receptor-class II-peptide interaction.
Aliases: BZLF2Glycoprotein 42 antibody, gp42) [Cleaved into: Soluble gp42] antibody
-
UniProt
- P03205
Target
-